Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two‐year clinical and radiographic results from the TEMPO study, a double‐blind, randomized trial
Désirée van der Heijde(Leiden University Medical Center), Vicente Rodrı́guez-Valverde(Marqués de Valdecilla University Hospital), Saeed Fatenejad, José Melo‐Gomes(Instituto Português de Malacologia), Lars Klareskog(Karolinska University Hospital), Jesús Tornero-Molina(Hospital Universitario de Guadalajara), H D Boloşiu, Cătălin Codreanu(Carol Davila University of Medicine and Pharmacy), Joseph Wajdula, Ronald Pedersen
Cited by 542
Related Papers
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
|The Lancet|2004|1.8k
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
|Pharmacology & Therapeutics|2007|1.6k
A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination
|Arthritis & Rheumatism|2005|1.5k
<i>STAT4</i> and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus
|New England Journal of Medicine|2007|1.1k
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis
|Nature Biotechnology|2013|1k